Clinical Trial Update: A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab Monotherapy in Participants With Select B-Cell Malignancies [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluates mosunetuzumab monotherapy for select B-cell malignancies, including Non-Hodgkin lymphoma, with the study currently listed as active…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• LUNSUMIO (mosunetuzumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Non-Hodgkin Lymphoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING